Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the ...

A Tuberculosis (TB) outbreak in Kansas City, Kansas, has people on edge, with not much public knowledge about the disease or ...

A recent study confirms that the 100-year-old BCG vaccine does not protect against COVID-19, challenging early assumptions ...

Currently the only approved vaccine for TB is the century-old Bacillus Calmette-Guerin (BCG) vaccine, which is widely used despite its effectiveness in adults being inconsistent. The study found ...

A live-attenuated tuberculosis (TB) vaccine candidate in development elicits a much more balanced and effective immune response compared to the existing vaccine used across much of the world, ...

Michigan has the only persisting bovine tuberculosis outbreak in wild deer anywhere in the U.S. — and it occasionally spills ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Since the classical observation that inoculation with live, but not killed, BCG confers protection against tuberculosis, the secretion of antigens has been considered crucial for maximizing ...

Notably, the delta sigH group had much lower levels of IDO, a protein known to cause more inflammation and make it difficult for the immune system to combat TB, compared to the BCG group.